Livia L. Szeto

Phase I Study of G3139, a <i>bcl-2</i> Antisense Oligonucleotide, Combined With Carboplatin and Etoposide in Patients With Small-Cell Lung Cancer

Charles M. Rudin, Mark Kozloff, Philip C. Hoffman et al. · Journal of Clinical Oncology · 2004 · 166 citations · Full text

Medicine, Oncology, Pharmacology +15

A pilot trial of G3139, a bcl-2 antisense oligonucleotide,and paclitaxel in patients with chemorefractory small-cell lung cancer

Charles M. Rudin, Gregory A. Otterson, Ann M. Mauer et al. · Annals of Oncology · 2002 · 155 citations · Full text

Medicine, Oncology, Pharmacology +11

Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion

Ramasamy Jagadeeswaran, Hanna Surawska, Soundararajan Krishnaswamy et al. · Cancer Research · 2008 · 120 citations · Full text

Medicine, Molecular Biology, Oncology +17

A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non–Small Cell Lung or Esophageal Cancer

Tanguy Y. Seiwert, Philip P. Connell, Ann M. Mauer et al. · Clinical Cancer Research · 2007 · 84 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

Nicholas W. Choong, Ann M. Mauer, Daniel J. Haraf et al. · Journal of Thoracic Oncology · 2008 · 70 citations · Full text

Medicine, Oncology, Pharmacology +8